Author:
Andrews Tory J.,Cox Robert D.,Parker Christina,Kolb James
Reference15 articles.
1. Management of type 2 diabetes: new and future developments in treatment;Tahrani;Lancet,2011
2. U.S. Food and Drug Administration. Drug safety communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm446845.htm. Accessed December 4, 2015.
3. Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors;Ogawa;J Diabetes Invest,2016
4. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition;Peters;Diabetes Care,2015
5. Hyperglycemic crises in adult patients with diabetes;Kitabchi;Diabetes Care,2009
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献